These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 31780181)
1. Pertussis vaccines: The first hundred years. Guiso N; Meade BD; Wirsing von König CH Vaccine; 2020 Jan; 38(5):1271-1276. PubMed ID: 31780181 [TBL] [Abstract][Full Text] [Related]
2. Licensed pertussis vaccines in the United States. History and current state. Klein NP Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496 [TBL] [Abstract][Full Text] [Related]
3. A life passion for vaccines. Pizza M Hum Vaccin; 2011 Aug; 7(8):808-10. PubMed ID: 22002174 [No Abstract] [Full Text] [Related]
4. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a single dose of acellular pertussis vaccine to prevent pertussis in children primed with pertussis whole cell vaccine. De Serres G; Shadmani R; Boulianne N; Duval B; Rochette L; Douville Fradet M; Halperin SA Vaccine; 2001 Apr; 19(20-22):3004-8. PubMed ID: 11282212 [TBL] [Abstract][Full Text] [Related]
6. Whole-cell or acellular pertussis vaccination in infancy determines IgG subclass profiles to DTaP booster vaccination. van der Lee S; Sanders EAM; Berbers GAM; Buisman AM Vaccine; 2018 Jan; 36(2):220-226. PubMed ID: 29199041 [TBL] [Abstract][Full Text] [Related]
7. Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses. Sheridan SL; Ware RS; Grimwood K; Lambert SB Vaccine; 2015 Sep; 33(39):5027-30. PubMed ID: 26297874 [TBL] [Abstract][Full Text] [Related]
8. Pertussis vaccination and whooping cough: and now what? Guiso N Expert Rev Vaccines; 2014 Oct; 13(10):1163-5. PubMed ID: 25020131 [TBL] [Abstract][Full Text] [Related]
9. Protective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis. Fulton TR; Phadke VK; Orenstein WA; Hinman AR; Johnson WD; Omer SB Clin Infect Dis; 2016 May; 62(9):1100-1110. PubMed ID: 26908803 [TBL] [Abstract][Full Text] [Related]
10. Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience. Thierry-Carstensen B; Dalby T; Stevner MA; Robbins JB; Schneerson R; Trollfors B Vaccine; 2013 Oct; 31(45):5178-91. PubMed ID: 23994021 [TBL] [Abstract][Full Text] [Related]
12. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles. van der Lee S; Hendrikx LH; Sanders EAM; Berbers GAM; Buisman AM Front Immunol; 2018; 9():51. PubMed ID: 29416544 [TBL] [Abstract][Full Text] [Related]
13. Development of improved vaccines against whooping cough: current status. Marzouqi I; Richmond P; Fry S; Wetherall J; Mukkur T Hum Vaccin; 2010 Jul; 6(7):543-53. PubMed ID: 20448470 [TBL] [Abstract][Full Text] [Related]
14. Shortcomings of pertussis vaccines: why we need a third generation vaccine. Poolman JT Expert Rev Vaccines; 2014 Oct; 13(10):1159-62. PubMed ID: 25089373 [TBL] [Abstract][Full Text] [Related]
16. The true story of pertussis vaccination: a sordid legacy? Geier D; Geier M J Hist Med Allied Sci; 2002 Jul; 57(3):249-84. PubMed ID: 12211972 [No Abstract] [Full Text] [Related]
17. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Olin P; Rasmussen F; Gustafsson L; Hallander HO; Heijbel H Lancet; 1997 Nov; 350(9091):1569-77. PubMed ID: 9393335 [TBL] [Abstract][Full Text] [Related]
18. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines. Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397 [TBL] [Abstract][Full Text] [Related]
20. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR; Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]